VHH selected against the viral spike protein can protect mice against lethal rabies virus challenge
2011

VHH Protects Mice from Rabies Virus

publication Evidence: moderate

Author Information

Author(s): Rosseels Valérie, Vanlandschoot Peter, Hultberg Anna, Verrips Theo, Saunders Michael, de Haard Hans, Francart Aurélie, Kalai Michael M, Van Gucht Steven

Primary Institution: Rabies Laboratory, Communicable and Infectious Diseases, Scientific Institute of Public Health, Brussels, Belgium

Hypothesis

Can VHH selected against the viral spike protein protect mice against lethal rabies virus challenge?

Conclusion

The study found that anti-G VHH can effectively protect mice from rabies virus infection.

Supporting Evidence

  • Anti-G VHH fully protected mice against disease and mortality when pre-incubated with the virus.
  • Preventive administration of anti-G VHH in the nose almost completely prevented disease.
  • Post exposure prophylaxis reduced mortality by 50% when administered shortly after virus challenge.

Takeaway

Scientists found a way to use special proteins to help mice fight off rabies virus, keeping them safe from getting sick.

Methodology

VHH were cloned from vaccinated llamas and tested for their ability to neutralize rabies virus in mice.

Limitations

Protection in the post-exposure prophylaxis model was weak, likely due to the short half-life of the VHH.

Participant Demographics

Mice were used in the study.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication